In the thyroid cancer arena, the study unveils the tricky identity crisis of anaplastic thyroid carcinoma (ATC). Often emerging from differentiated thyroid carcinoma (DTC), ATC’s rebel nature complicates diagnosis. Researchers scoured 36 cases, discovering ATC’s deceptive biomarker profile. While TTF1 stays mum, PAX8 and divergent markers like GATA3 and SATB2 stage a confusing spectacle. These markers, akin to other malignancies, turn ATC diagnosis into a diagnostic puzzle, revealing the nuanced challenge of distinguishing it from its high-grade neck rivals.
Journal Article by Mneimneh WS and Asa SL in Am J Surg Pathol
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.